Clearside Biomedical Inc (CLM.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
As of 09:24AM CEST. Market open.
| Previous close | 1.1600 |
| Open | 1.2400 |
| Bid | 1.2400 x N/A |
| Ask | 1.2800 x N/A |
| Day's range | 1.2400 - 1.2400 |
| 52-week range | 0.6250 - 1.9200 |
| Volume | |
| Avg. volume | 45 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Misses Revenue Estimates
Clearside Biomedical (CLSD) delivered earnings and revenue surprises of -21.43% and 76.43%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
- Simply Wall St.
Clearside Biomedical Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line
Clearside Biomedical ( NASDAQ:CLSD ) Full Year 2023 Results Key Financial Results Revenue: US$8.23m (up by US$6.90m...
- Insider Monkey
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript
Clearside Biomedical, Inc. (NASDAQ:CLSD) Q4 2023 Earnings Call Transcript March 13, 2024 Clearside Biomedical, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings, and welcome to the Clearside Biomedical Q4 2023 Financial Results and Corporate Update Call. At this […]
© 2024 Yahoo. All rights reserved.